Company ProfilePremium

Hills Limited

Company Profile Analysis

Ticker: HIL.AX

ESOMAR 23 Corporate BadgeISO Certifications Badge
Hills Limited - Company showcase

Year Founded & Workforce

1945

350 Employees

Hills Limited logo

Hills Limited Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Hills Limited Overview

Hills Limited is one of Australia's oldest industrial names, born from the Hills Hoist rotary clothesline and later reinvented, in sequence, as a diversified industrial conglomerate, a building-technology distributor, and finally a niche health-technology and technical-services business. By 2022 it had sold its security/IT distribution arm to Dicker Data and its AV business to Amber Technology, leaving two segments: Hills Health Solutions — an Australian-designed and manufactured Nurse Call and patient engagement (bedside infotainment, guest Wi-Fi) platform deployed across roughly 1,400 hospital and aged-care sites in Australia and New Zealand — and Hills Technical Solutions, a field installation and maintenance services unit. A long-running contract dispute with Stellar Vision Operations, decided against Hills on appeal in May 2023, triggered administration. The business survived via a creditor-approved DOCA that transferred ownership to Starplex International, a Stellar-related party. It is now a privately held, sub-scale but entrenched specialist in clinical communications.


Company's own description (latest public reports, FY2022/H1 FY2023). In its final disclosures, Hills described itself as a provider of end-to-end, business-to-business solutions in the building technologies sector, operating through two reportable segments. Hills Health Solutions (HHS) designs, supplies, installs and maintains health technology solutions — principally Nurse Call and patient engagement systems — together with related security, Wi-Fi and telephony into health and aged-care settings. Hills Technical Solutions (HTS) provides technology installation and maintenance services for residential and commercial premises across Australia and New Zealand. (Source: Hills Limited Interim Financial Report, half year to 31 Dec 2022; MarketScreener company profile.)

Independent characterisation. At the end of its listed life Hills was effectively a single-thesis health-technology company carrying a residual services arm and a heavy legacy cost and legal burden. The economic core was HHS: proprietary Nurse Call intellectual property, owned and developed in Australia, sold primarily into large public-hospital construction and refurbishment projects (often as a subcontractor to head builders and PPP consortia), with a recurring tail from maintenance, patient-engagement bed subscriptions and guest Wi-Fi. Management emphasised that ownership of Nurse Call IP was its key differentiator versus distributors of imported systems.

Business model and revenue mix.

Value chain position. HHS sits as an OEM/solution integrator (owns and develops Nurse Call hardware/software; integrates third-party platforms such as GetWellNetwork, Olinqua critical messaging). HTS sits at the installation/field-service layer. Before 2022, Hills also sat in the middle of the value chain as a value-added distributor of third-party security, surveillance, IT and AV products.

Customer types and end-markets. Public health systems (state health departments, local health districts in NSW, Western Health in Victoria), private hospital operators, aged-care providers, construction head contractors and PPP consortia (e.g., Plenary Health/Multiplex), and residential/commercial property owners (HTS).

Strategy

Last stated strategy (FY2021–FY2023). Following the 2022 divestment, management repositioned Hills as a health-technology-led company, stating an intention to invest in sales, marketing, technical and research capability to expand health technology revenue. Themes: (1) leverage owned Nurse Call IP as the differentiator versus importers; (2) move up the sophistication ladder through patient engagement (GetWell) and integration (Olinqua critical messaging); (3) extend into connected care and aged care (Extensia); (4) shed loss-making non-core operations (SIT, NZ); (5) recapitalise the balance sheet (April 2023 placement with a cornerstone investor).

Medium-term financial targets/guidance: none publicly disclosed since FY2021. ESG commitments: not publicly disclosed.

Products & Services

Hills Health Solutions

OfferingDescription / capabilitiesTarget customerYearPricing modelFlagship deployments
Hills Nurse Call (IP platform)Australian-designed and manufactured clinical communications platform; evolved from a call "buzzer" into the hub of hospital communications, integrating third-party systems — emergency response, digital signage, real-time location, fire and securityPublic and private hospitalsOngoing development; latest version year not disclosedProject supply/install plus maintenance; not disclosedWestmead Central Acute Services Building (NSW); New Footscray Hospital (VIC, 500+ beds, ~A$7m); projects at Casey, Western Health, Alfred, Royal Hobart (H2 FY2020)
"Smart hospital room" terminalsSmart touchscreen terminals in each patient room integrated with Nurse Call for workflow management and reportingMajor new-build hospitals2022 (Footscray)Bundled in projectNew Footscray Hospital
Wireless Nurse CallLower-cost wireless Nurse Call aimed at facilities constrained on cost or retrofitAged care, smaller hospitalsLaunch year not disclosed——
Patient engagement / bedside infotainmentBedside entertainment, communication and education systemsPublic hospitalsOngoingPer-bed / subscription (not disclosed)1,060 net new beds and 2,800 beds renewed at 15 hospitals (H1 FY2020)
GetWell Network / GetWell LoopDistributed under three-year agreement with US-based GetWellNetwork (from Mar 2021); interactive patient engagement and remote patient engagementHospitals, private surgical facilities2,021—Kaweka Health (Hawke's Bay, NZ)
Guest Wi-FiManaged patient/visitor Wi-FiNSW HealthOngoingPer-bed / managed service13 NSW Health districts, >4,300 beds (H1 FY2020)
Healthily TV (JV)Joint venture with patient-education specialist Healthily delivering evidence-based health content through Hills bedside platformsHospitalsLate 2010s——
Olinqua integrationConverged IP platform combining Hills Nurse Call with Olinqua critical messagingHospitals2,022——
Extensia connected careConnected-care / home and aged-care monitoring (majority stake acquired Mar 2022)Aged care, community care2,022——
Home monitoring for older peopleSystem tracking deviations from daily routines; dementia monitoring software development reportedAged/community care———
Security, telephonyAncillary building technologies sold into health settingsHealth, aged careOngoing——

Installed base metrics. More than 40% of Australian public hospital beds and over 20% of private hospital beds used Hills Nurse Call or patient engagement systems (FY2019 annual report, via InDaily). Technology present in more than 1,400 hospital and aged-care sites across ANZ (company event profile). In 2016 the company cited presence in 400 hospitals and 570 aged-care facilities.

Hills Technical Solutions

OfferingDescriptionTarget customerPricingNotes
Technology installationInstallation of communications/technology in residential and commercial premisesProperty owners, builders, telcosBillable per job (not disclosed)Heavily linked to construction activity
Maintenance servicesOngoing maintenance of installed technologyCommercial customers——
Hills Connection Services (historical)NBN-related connection work; partnerships with Downer EDI and Lendlease cited in FY2019Telcos/contractors—NBN satellite installation exited in FY2017

Divested portfolio (historical, for context)

BusinessContentExit
Security & IT distribution (SIT)Largest distributor of physical security products in Australia; 50+ vendor contracts (incl. Genetec, Axis, BQT Solutions, Tyco brands)Sold to Dicker Data, completed 1 May 2022 (now Dicker Data Access & Surveillance)
Audio Visual (ANZ)Pro AV distributionSold to Amber Technology (Ambertech), announced Nov 2019
Hills Home Living (Hills Hoist, clotheslines, home products)Consumer productsSold; owned by AMES Australasia since 2017
Industrial (Korvest, Orrcon)Steel/industrial productsDivested c. 2013
Hills UKEuropean operationsSold to Freudenberg, 2006

Financial Narrative

Basis warning. FY2018–FY2021 figures are whole-group (including distribution). FY2022 is restated to continuing operations only (HHS + HTS) after the SIT sale and NZ closure; it is therefore not comparable. FY2023 full-year accounts were never published (administration from June 2023).

Income statement

Sources: ARN (FY2018), InDaily/FY2019 annual report, Hills FY2021 Appendix 4E (FY2020/FY2021 NPAT), TechPartner News (FY2020/FY2021 revenue), Wikipedia infobox citing FY2022 (revenue ~A$47m). Note: the last dividend was A$0.02/share paid 30 Apr 2015 (InvestSMART), so DPS was nil throughout FY2018–FY2022.

Other verified data points.

Note: ARN reported FY2017 revenue as A$298m; a later ARN article implies FY2017 revenue of A$298.1m (A$271.8m + A$26.3m decline). Consistent.

Margins and growth

Revenue CAGR FY2018–FY2021 (whole-group basis): approximately –9.7% per annum (A$271.8m to A$180.2m over three years). A FY2018–FY2022 CAGR is not meaningful because of the FY2022 basis change.

Balance sheet

FY2021 net debt of A$13.2m and an A$8.5m reduction in capital employed are from the FY2021 annual report. Pre-2022 debt was provided by Commonwealth Bank of Australia (CBA consent was a condition of the SIT sale); by 2023 the secured lender was the Causeway Wholesale Private Debt Master Fund (whose security trustee appointed administrators). Short/long debt split: not publicly disclosed. Unrecognised tax losses: A$257.78m (administrators' disclosure, 2023).

Cash flow

Government support: JobKeeper receipts of A$2.95m in Q1 FY2021; JobSaver benefits of A$0.5m in H1 FY2022 (company disclosures).

Ratios

ROE, ROA, ROIC, current ratio, debt/equity, net debt/EBITDA, interest coverage, asset turnover and cash conversion cycle cannot be calculated reliably from the verified dataset and are not publicly disclosed in secondary sources. Qualitatively: with persistent net losses from FY2019 onward, ROE and ROA were negative in every year from FY2019 to H1 FY2023; MarketScreener showed P/E of roughly –0.6x for FY2022/23 and EV/Sales of 0.37x (FY2022) and 0.14x (FY2023 estimate).

Commentary

The five-year arc is one of shrinkage without a return to sustainable profit. Group revenue fell from about A$330m in FY2016 to A$180m by FY2021 as Hills exited low-margin distribution lines, NBN satellite work, AV (2019) and finally core security/IT distribution (2022). The only profitable full year in the period was FY2018 (NPAT A$0.4m on EBITDA of A$9.4m). FY2019's statutory loss was driven by restructuring provisions (A$7.7m) and impairments (A$6.5m); FY2020 and FY2021 losses reflected COVID-19 lockdowns restricting hospital access, the global semiconductor shortage, NZ losses (A$1.9m operating loss in FY2021), legal costs (A$3.1m in FY2021) and a A$2.8m non-cash tax expense from derecognising NZ tax losses. After the SIT sale, the continuing business was roughly a A$45–47m revenue operation that remained loss-making (H1 FY2023 continuing loss of A$3.6m; operating EBITDA –A$0.6m versus +A$0.7m in the prior half). This left no buffer to absorb the ~A$5.5m Stellar judgment plus costs, which precipitated administration in June 2023.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Segment Overview

SegmentContentsProducts/services

Hills Health Solutions (HHS)

Health technology design, manufacture, supply, installation and maintenance

Nurse Call (wired and wireless), patient engagement/bedside infotainment, GetWell platform, guest Wi-Fi, security, telephony into health and aged care; Extensia connected care

Hills Technical Solutions (HTS)

Field technology installation and maintenance

Residential and commercial installation and maintenance services (ANZ)

Discontinued (FY2022)

Security & IT distribution (Australia) — sold to Dicker Data; New Zealand operations — closed

Distribution of security, surveillance and IT products (incl. Genetec, others)

Results by Segment

MetricH1FY2022H1FY2023

Revenue continuing operations (AUD Mn)

22.63322.499

Revenue discontinued operations (AUD Mn)

57.3460.122

Net loss continuing operations (AUD Mn)

-4.791-3.606

Net loss discontinued operations (AUD Mn)

-15.251-0.222

Total net loss (AUD Mn)

-20.042-3.828

Revenue by Segment

MetricFY2022

Continuing group revenue (AUD Mn)

47

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Income Statement

MetricFY2018FY2019FY2020FY2021FY2022

Revenue (AUD Mn)

271.8—220.1180.247

EBITDA (AUD Mn)

9.4————

Net income (AUD Mn)

0.4-8.8-6.53-10.224—

Underlying NPAT (AUD Mn)

—0.5———

Dividends per share (AUD cents)

00000

Income Statement (FY2015–FY2017)

MetricFY2015FY2016FY2017

Revenue (AUD Mn)

—328.9298

Net income (AUD Mn)

-85.9-68.3-7.9

Margin Analysis (%)

MetricFY2018FY2020FY2021

EBITDA margin (%)

3.5——

Net margin (%)

0.1-3.0-5.7

Revenue growth YoY (%)

-8.8—-18.1

Key Financials

MetricFY2021

Net debt (AUD Mn)

13.2

Financial Analysis

MetricFY2018FY2019FY2020FY2021FY2022

Dividends paid (AUD Mn)

00000

Buybacks (AUD Mn)

00000

Revenue by Region and Results by Region

MetricFY2019FY2020FY2021

Hills NZ revenue (NZD Mn)

2015.3—

Hills NZ net result (NZD Mn)

-0.676-2.3—

Hills NZ operating result (AUD Mn)

—-1.4-1.9

Valuation Snapshot

MetricValue

Last traded price

A$0.023 (May 2023)

Last listed market cap

~A$12.3m (Simply Wall St)

1-year return to delisting

Approximately –68% vs ASX 200 (Market Index, final data)

P/E (FY2022/FY2023)

~–0.6x (MarketScreener)

EV/Sales

0.37x FY2022; 0.14x FY2023 estimate (MarketScreener)

Analyst consensus

None (Simply Wall St listed 5 analysts historically; Market Index: no major broker coverage)

Credit ratings

None (unrated)

Shareholder outcome

Shares transferred to Starplex for nil consideration under DOCA

Capital Markets

MetricFY2018FY2019FY2020FY2021FY2022

Dividend per share (AUD cents)

00000

Analyst Conclusions

Management guidance. None published since FY2021; post-DOCA owner Starplex has issued no public targets. Consensus: not applicable.

Bull case

  1. The Nurse Call franchise is genuinely entrenched — a 40%+ public-hospital-bed share and ~1,400 sites provide a durable maintenance and upgrade annuity that a cleaned-up balance sheet (post-DOCA debt compromise) can finally monetise.

  2. Combination with Stellar-related patient engagement capability under one owner could create a more complete bedside-to-nurse-station platform.

  3. Up to A$257.78m in tax losses, if usable, materially enhances after-tax returns for the new owner.

Bear case

  1. The continuing business was loss-making at the EBITDA line even before administration (–A$0.6m in H1 FY2023), suggesting structural sub-scale economics.

  2. Procurement teams may penalise a supplier with a recent insolvency on long-life clinical systems, eroding win rates.

  3. Global competitors with larger R&D budgets may outpace a small private developer in IP-based, software-led clinical communications.

Monitorables (next 12 months): any ASIC filings revealing Starplex group financials; New Footscray Hospital commissioning and follow-on hospital awards; renewal status of GetWell/Olinqua partnerships; executive changes (whether David Clarke remains); any re-listing or trade sale of the health business.

Analyst verdict. Hills Limited is no longer an investable listed security: its 61-year ASX listing ended in August 2023, and the court-sanctioned transfer of its shares to Starplex International left former shareholders with nothing. For counterparties, competitors and potential acquirers, however, the residual business remains strategically relevant. Hills Health Solutions controls an unusually deep installed base of Australian-developed Nurse Call and patient engagement systems in public hospitals, and that base produced steady project wins even as the wider group was being dismantled — Westmead, New Footscray and a string of Victorian and Tasmanian projects. The core lesson from Hills' decline is that a valuable niche franchise was repeatedly undermined by group-level problems: a sprawling distribution business that never earned its cost of capital, serial restructurings and impairments, and finally an inherited contract dispute that a shrunken, loss-making company could not absorb. The DOCA has compromised legacy liabilities and placed the business under an owner aligned with its former litigant, which removes the immediate legal overhang and may allow integration of complementary patient engagement assets. The key question is whether the health business, at roughly A$45–50m of revenue, can generate positive operating cash flow on a standalone basis while funding the R&D needed to keep pace with global clinical-communications vendors. Evidence from the final listed periods is not encouraging, but those periods carried listed-company overheads, NZ losses and legal costs that should not recur. Our assessment: a credible but fragile private niche operator whose value lies in its installed base and Australian IP; most likely end-states are continued private operation as part of a Starplex/Stellar health-technology group, or an eventual trade sale to a strategic clinical-communications player seeking ANZ hospital share. Absent new public disclosures, all forward views carry high uncertainty.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Executive Leadership Team

NameRoleTenureBackground

David Clarke

CEO (from 17 May 2021); Managing Director (from 30 Sep 2022)

2021–(post-administration status not disclosed)

BCom, DipGrad, CA, GAICD; seven years at ASX-listed health software provider Corum Group (four as CEO); prior roles at Medtronic Australasia, Fisher & Paykel and Nick Scali. Held ~0.14% of shares (Simply Wall St)

David Chambers

Chairman

—

Per Wikipedia infobox

Janet Muir

Non-executive director

Resigned 30 Sep 2022

—

David Lenz

Former CEO & MD

Aug 2016 – retired 1 Jul 2021

Previously COO and head of Building Technologies

James Layton

Acting head of distribution (Australia)

Appointed under Lenz (c. 2020–21)

Ex-Ingram Micro, Bosch, Direct Alarm Supplies

Andy Hall

Head of Hills Health Solutions (promoted from GM health sales)

——

“—” = not publicly disclosed.

Major Shareholders

HolderSharesStake (%)

Poplar Pty Limited

16,550,8457.13

Hills Associates Limited

13,455,6895.80

Cambrose Pty Limited

4,676,5102.02

HSBC Custody Nominees (Australia) Limited

3,597,8551.55

Hills Associates Pty Ltd

3,212,7521.38

Carrier International Pty Limited

3,071,6981.32

Competitive Landscape

Key Competitors

CompetitorSegment overlapNotes / positioning

Ascom (Switzerland)

Nurse call, clinical communications

Global; strong in ANZ hospitals

Hillrom / Baxter (US)

Nurse call (Voalte, Navicare), beds

Global scale; bed integration

Austco Healthcare (Australia, ASX: AHC)

Nurse call, clinical communications

Closest listed local peer; Australian-made IP

Jeron, Rauland (AMETEK)

Nurse call

Global/US-centric

Tunstall

Aged-care nurse call, telecare

Strong in aged/community care

Vocera (Stryker)

Clinical communications

Hands-free/mobile communications

Lincor Solutions

Patient engagement

Former merger partner

Stellar Vision Operations

Patient engagement (PES)

Litigation counterparty; related to new owner

Telstra Health

Patient engagement / digital health

Large telco-backed player

Downer, Service Stream, UGL

Field technical services (vs HTS)

Much larger contractors

Competitor Detail

MetricHills (FY2022)

Revenue

~A$47m

Growth

Negative

Margin

Loss-making

Recent Developments

Note: * Because Hills has been private since late 2023, there has been essentially no public newsflow in the 18 months to October 2026 (April 2025 – October 2026).

Company Snapshot

$32.6M

Revenue

350

Employees

1945

Founded

Historically Adelaide, Australia

Headquarters

SWOT Analysis

Strengths

  • Market-leading installed base: Nurse Call/patient engagement used in over 40% of Australian public hospital beds and over 20% of private beds (FY2019 annual report).
  • Owned, Australian-developed Nurse Call IP, emphasised by management as its differentiator (Westmead announcement).
  • Presence in ~1,400 hospital and aged-care sites across ANZ with 130+ health technology specialists.
  • Proven large-project delivery: Westmead CASB, New Footscray (500+ beds, ~A$7m), Casey, Alfred, Royal Hobart.
  • Recurring per-bed revenue streams: guest Wi-Fi across 13 NSW Health districts and 4,300+ beds (H1 FY2020).
  • Survived insolvency with business continuity: operated in the ordinary course throughout administration and emerged under a DOCA (Nov 2023).

Weaknesses

  • Chronic losses: net losses in FY2019, FY2020, FY2021, FY2022 and H1 FY2023.
  • Sub-scale after divestments: continuing revenue ~A$47m (FY2022) versus A$271.8m (FY2018).
  • Negative operating EBITDA (–A$0.6m, H1 FY2023).
  • Thin balance sheet unable to absorb a ~A$5.5m legal judgment.
  • History of failed transactions (Lincor merger terminated 2017).
  • Repeated leadership and strategic pivots (conglomerate → distributor → health tech in ~10 years).

Opportunities

  • Hospital construction pipeline in NSW and Victoria.
  • Aged-care reform and connected care (Extensia platform).
  • Integration partnerships (Olinqua, GetWell) to lift value per bed.
  • A$257.78m of unrecognised tax losses potentially valuable to the new owner (subject to tax law continuity tests).
  • Combination with Starplex/Stellar-related patient engagement assets.
  • Wireless Nurse Call for cost-sensitive retrofit market.

Threats

  • Global competitors with greater R&D budgets (Ascom, Baxter/Hillrom, Stryker/Vocera).
  • Customer and head-contractor concern over supplier solvency post-administration.
  • Project timing risk tied to construction schedules.
  • Contract litigation risk (as shown by the Questek/Stellar dispute).
  • Component supply constraints (semiconductor shortage cited in FY2021).
  • Loss of distribution agreements (e.g., GetWell three-year deal from 2021 may have lapsed; renewal status not disclosed).

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
30 Mar 2021GetWellNetwork distribution dealPatient engagement upgrade
17 May 2021David Clarke named CEOHealth-focused leadership
1 Jul 2021David Lenz retiresLeadership transition complete
31 Aug 2021FY2021 loss of A$10.2m on A$180.2m revenueDeteriorating trading
Late 2021Review and workplace change process for NZ businessPrecursor to NZ exit
8 Dec 2021Kaweka Health (NZ) selects GetWell via HillsHealth contract win
18 Jan 2022Olinqua partnershipProduct extension
Feb 2022Supreme Court dismisses Stellar claim; costs to HillsTemporary legal relief
21 Feb 2022SIT sale to Dicker Data announcedStrategic pivot
28 Feb 2022H1 FY2022 results incl. transaction impact; total net loss A$20.0mLarge write-downs/discontinued losses
Mar 2022Extensia majority stakeConnected care
Apr 2022Shareholder approval of SIT sale (general meeting expected early April)Deal condition
1 May 2022SIT sale completesGroup shrinks to ~A$47m revenue
23 May 2022Joins aged-care vendor consortiumMarket development
6 Sep 2022New Footscray Hospital ~A$7m Nurse Call winLargest recent contract
26 Sep 2022FY2022 annual report released (last ever)Final annual report
30 Sep 2022Clarke appointed MD; Muir resignsBoard change
28 Feb 2023H1 FY2023: continuing net loss A$3.6m; EBITDA –A$0.6mContinued losses
Apr 2023Capital raising with cornerstone investorRecapitalisation attempt
May 2023Court of Appeal rules for Stellar (~A$5.48m plus costs)Trigger event
25 May 2023Trading suspensionListing jeopardised
26 May 2023Standstill deed with Stellar disclosedSettlement negotiations
2 Jun 2023Joint administrators appointed by secured lender's trusteeInsolvency
Jun–Aug 2023Sale/recapitalisation process: 51 EOIs, 13 NBIOs, 7 shortlistedMarket test
23 Aug 2023Starplex DOCA executed (68.39c/$)Creditor outcome
28 Aug 2023Removed from ASX Official ListEnd of 61-year listing
Oct–Dec 2023NSW Supreme Court grants s444GA share transfer leave (affidavit dated 23 Oct 2023)Shareholders extinguished
8 Nov 2023Hills reported to emerge from administrationBusiness continues privately

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

4 charts
Revenue by Segment: Continuing group revenue was AUD 47 Mn in FY2022.
Hills Limited — Revenue by Segment
Series (AUD Mn)FY2022
Continuing group revenue47

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. Wikipedia — Hills Limited (history, name changes, FY2022 infobox figures)
  2. ASX Settlement notice 0532.23.06 (suspension, administrator appointment), asxonline.com
  3. ASX market announcement, 29 Aug 2023 — Removal from Official List (Listing Rule 17.15)
  4. Hills Limited Interim Financial Report, half year ended 31 Dec 2022 (ASX, 28 Feb 2023)
  5. Hills Limited Appendix 4E and Annual Report, year ended 30 Jun 2021 (ASX, 31 Aug 2021)
  6. Business News Australia — administrators appointed (Jun 2023); creditors approve DOCA (Aug 2023)
  7. Hall & Wilcox — "Navigating share transfers in a deed of company arrangement" (15 Feb 2024)
  8. ARN — Hills appoints administrators; Hills results FY2017; Hills first profit FY2018; Layton appointment
  9. Newcastle Herald — Hills administration and AMES ownership of Hills Hoist
  10. Dicker Data ASX releases (21 Feb 2022; 30 Aug 2022; 30 Aug 2023); BDO deal note (SIT sale ~A$20m)
  11. TechPartner News — FY2021 results; H1 FY2017 results/Lincor
  12. Reseller News NZ — Hills NZ review
  13. InDaily — FY2019 results and hospital bed share
  14. Australian Security Magazine — H1 FY2020 results; Genetec/OPS; Westmead Nurse Call
  15. Pulse+IT — Hills Health Solutions coverage (2021–Nov 2023)
  16. Healthcare IT News; iTWire — New Footscray Hospital contract
  17. Market Index; Motley Fool; Simply Wall St; MarketScreener; InvestSMART — shareholders, last price, multiples, dividend history
  18. FinNews Network — AV sale to Amber Technology (Nov 2019)

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.